2021
DOI: 10.1155/2021/5524772
|View full text |Cite
|
Sign up to set email alerts
|

High-Throughput Untargeted Serum Metabolomics Analysis of Hyperuricemia Patients by UPLC-Q-TOF/MS

Abstract: Hyperuricemia (HUA) as a metabolic disease is closely associated with metabolic disorders. The etiology and pathogenesis of HUA are not fully understood, so there is no radical cure so far. Metabolomics, a specialized study of endogenous small molecule substances, has become a powerful tool for metabolic pathway analysis of selected differential metabolites, which is helpful for initially revealing possible development mechanisms of various human diseases. Twenty HUA patients and 20 healthy individuals partici… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

5
23
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 23 publications
(28 citation statements)
references
References 45 publications
5
23
0
Order By: Relevance
“…Metabolomics is an emerging field of research that has been used to evaluate metabolic perturbations associated with different stages of diseases, identify disease biomarkers, explore potential targets and predict drug safety and efficacy ( Shan et al, 2020 ; Zhao et al, 2020 ; Song et al, 2021 ). Non-targeted metabolomics has been conducted extensively to explore biomarkers related to effective hyperuricaemia treatments ( Qin et al, 2021 ; Zhang et al, 2021 ). Therefore, metabolomics based on UHPLC-QE-MS, which is suitable for simultaneous and systemic analysis of multiple metabolite fingerprinting, was employed to generate metabolite profiles of urine to characterize the metabolic changes related to hyperuricaemia and uncover the underlying metabolic mechanism of the therapeutic effects of WPP and CPP on gout.…”
Section: Discussionmentioning
confidence: 99%
“…Metabolomics is an emerging field of research that has been used to evaluate metabolic perturbations associated with different stages of diseases, identify disease biomarkers, explore potential targets and predict drug safety and efficacy ( Shan et al, 2020 ; Zhao et al, 2020 ; Song et al, 2021 ). Non-targeted metabolomics has been conducted extensively to explore biomarkers related to effective hyperuricaemia treatments ( Qin et al, 2021 ; Zhang et al, 2021 ). Therefore, metabolomics based on UHPLC-QE-MS, which is suitable for simultaneous and systemic analysis of multiple metabolite fingerprinting, was employed to generate metabolite profiles of urine to characterize the metabolic changes related to hyperuricaemia and uncover the underlying metabolic mechanism of the therapeutic effects of WPP and CPP on gout.…”
Section: Discussionmentioning
confidence: 99%
“…In this research-based on the previous research method 20 , MeOH/MeCN (1:9, v/v) was used to extract serum samples of HUA patients. The extraction effect was not only better than that of pure solvent but also more complete non-targeted metabolic information could be obtained.…”
Section: Discussionmentioning
confidence: 99%
“…If a serum precipitation solvent suitable for HUA metabolomics analysis must be recommended, then MeOH/MeCN (1:9, v/v) can be used for analysis 20 . Frozen serum samples were thawed at 4 °C.…”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations